Skip to main content
Log in

Knockdown of p62/sequestosome 1 attenuates autophagy and inhibits colorectal cancer cell growth

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

p62/sequestosome-1 is a multifunctional adapter protein implicated in selective autophagy, cell signaling pathways, and tumorigenesis, and plays an important role at the crossroad between autophagy and cancer. But, the connection between autophagy and cancer is complex and in some cases contradictory. Human colorectal cancer tissues from patients were analyzed for expression of p62 and Microtubule-associated protein light chain 3 (LC3, an autophagosome marker) using immunostaining, western blotting, real-time PCR, and confocal microscopy. To study the effects of p62 on autophagy and cell growth, shRNA for p62 was applied and cell growth curve was monitored in human colorectal cancer cell. In vivo experiments were done using the mouse xenograft model. We showed that up-regulated expression of p62 and LC3 in colorectal cancer tissues. We also demonstrated that specifically knockdown the expression of p62 showed significantly inhibitory effects not only on autophagy activation, but also on tumor growth both in vitro and xenograft tumors model. The ectopic overexpression of p62 and autophagy activation contributes to colorectal tumorigenesis. p62 and autophagy will be therapy targets for the treatment of colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Johansen T, Lamark T (2011) Selective autophagy mediated by autophagic adapter proteins. Autophagy 7(3):279–296

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Moscat J, Diaz-Meco MT (2009) p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137(6):1001–1004. doi:10.1016/j.cell.2009.05.023

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Puissant A, Fenouille N, Auberger P (2012) When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res 2(4):397–413

    PubMed Central  CAS  PubMed  Google Scholar 

  4. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, Dipaola RS, Karantza-Wadsworth V, White E (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137(6):1062–1075. doi:10.1016/j.cell.2009.03.048

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Stumptner C, Heid H, Fuchsbichler A, Hauser H, Mischinger HJ, Zatloukal K, Denk H (1999) Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent. Am J Pathol 154(6):1701–1710. doi:10.1016/S0002-9440(10)65426-0

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Thompson HG, Harris JW, Wold BJ, Lin F, Brody JP (2003) p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene 22(15):2322–2333. doi:10.1038/sj.onc.1206325

    Article  CAS  PubMed  Google Scholar 

  7. Su Y, Qian H, Zhang J, Wang S, Shi P, Peng X (2005) The diversity expression of p62 in digestive system cancers. Clin Immunol 116(2):118–123. doi:10.1016/j.clim.2005.04.004

    Article  CAS  PubMed  Google Scholar 

  8. Kitamura H, Torigoe T, Asanuma H, Hisasue SI, Suzuki K, Tsukamoto T, Satoh M, Sato N (2006) Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue. Histopathology 48(2):157–161. doi:10.1111/j.1365-2559.2005.02313.x

    Article  CAS  PubMed  Google Scholar 

  9. Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, Sugawara S, Watanabe M, Sakurada A, Endo C, Uruno A, Sasano H, Nakagawa T, Satoh K, Tanaka N, Kubo H, Motohashi H, Yamamoto M (2012) Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci 103(4):760–766. doi:10.1111/j.1349-7006.2012.02216.x

    Article  CAS  PubMed  Google Scholar 

  10. Bampton ET, Goemans CG, Niranjan D, Mizushima N, Tolkovsky AM (2005) The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes. Autophagy 1(1):23–36

    Article  CAS  PubMed  Google Scholar 

  11. Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140(3):313–326. doi:10.1016/j.cell.2010.01.028

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Komatsu M (2011) Potential role of p62 in tumor development. Autophagy 7(9):1088–1090

    Article  CAS  PubMed  Google Scholar 

  13. Moscat J, Diaz-Meco MT (2012) p62: a versatile multitasker takes on cancer. Trends Biochem Sci 37(6):230–236. doi:10.1016/j.tibs.2012.02.008

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Nezis IP, Stenmark H (2012) p62 at the interface of autophagy, oxidative stress signaling, and cancer. Antioxid Redox Signal 17(5):786–793. doi:10.1089/ars.2011.4394

    Article  CAS  PubMed  Google Scholar 

  15. Rolland P, Madjd Z, Durrant L, Ellis IO, Layfield R, Spendlove I (2007) The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease. Endocr Relat Cancer 14(1):73–80. doi:10.1677/erc.1.01312

    Article  PubMed  Google Scholar 

  16. Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K, Hino O, Watanabe S, Ando J, Iwadate M, Yamamoto M, Lee MS, Tanaka K, Komatsu M (2011) Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 193(2):275–284. doi:10.1083/jcb.201102031jcb.201102031

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Myung Park J, Huang S, Wu TT, Foster NR, Sinicrope FA (2012) Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther 14(2):100–107

    Article  Google Scholar 

  18. Duran A, Amanchy R, Linares JF, Joshi J, Abu-Baker S, Porollo A, Hansen M, Moscat J, Diaz-Meco MT (2011) p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell 44(1):134–146. doi:10.1016/j.molcel.2011.06.038

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282(33):24131–24145. doi:10.1074/jbc.M702824200

    Article  CAS  PubMed  Google Scholar 

  20. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, Warabi E, Yoshida H, Ishii T, Kobayashi A, Yamamoto M, Yue Z, Uchiyama Y, Kominami E, Tanaka K (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131(6):1149–1163. doi:10.1016/j.cell.2007.10.035

    Article  CAS  PubMed  Google Scholar 

  21. Zheng Q, Su H, Ranek MJ, Wang X (2011) Autophagy and p62 in cardiac proteinopathy. Circ Res 109(3):296–308. doi:10.1161/CIRCRESAHA.111.244707CIRCRESAHA.111.244707

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H (2002) p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160(1):255–263. doi:10.1016/S0002-9440(10)64369-6

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Kirkin V, McEwan DG, Novak I, Dikic I (2009) A role for ubiquitin in selective autophagy. Mol Cell 34(3):259–269. doi:10.1016/j.molcel.2009.04.026

    Article  CAS  PubMed  Google Scholar 

  24. Viiri J, Hyttinen JM, Ryhanen T, Rilla K, Paimela T, Kuusisto E, Siitonen A, Urtti A, Salminen A, Kaarniranta K (2010) p62/sequestosome 1 as a regulator of proteasome inhibitor-induced autophagy in human retinal pigment epithelial cells. Mol Vis 16:1399–1414. doi:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913138/

    PubMed Central  CAS  PubMed  Google Scholar 

  25. Parkhitko A, Myachina F, Morrison TA, Hindi KM, Auricchio N, Karbowniczek M, Wu JJ, Finkel T, Kwiatkowski DJ, Yu JJ, Henske EP (2011) Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Proc Natl Acad Sci USA 108(30):12455–12460. doi:10.1073/pnas.1104361108

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K, Mizushima N (2011) Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25(8):795–800. doi:10.1101/gad.2016211

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Grants No. 2013TT2022 from Hunan Provincial Science and Technology Department.

Conflict of interests

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jianping Zhou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ren, F., Shu, G., Liu, G. et al. Knockdown of p62/sequestosome 1 attenuates autophagy and inhibits colorectal cancer cell growth. Mol Cell Biochem 385, 95–102 (2014). https://doi.org/10.1007/s11010-013-1818-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-013-1818-0

Keywords

Navigation